Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure von Fox, Kim, Ford, Ian, Steg, Philippe Gabriel, Tardif, Jean-Claude, Tendera, Michal, Ferrari, Roberto

Volltext

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial von Tardif, Jean-Claude, Ballantyne, Christie M, Barter, Philip, Dasseux, Jean-Louis, Fayad, Zahi A, Guertin, Marie-Claude, Kastelein, John J P, Keyserling, Constance, Klepp, Heather, Koenig, Wolfgang, L'Allier, Philippe L, Lespérance, Jacques, Lüscher, Thomas F, Paolini, John F, Tawakol, Ahmed, Waters, David D

Volltext

Icosapent Ethyl diminishes CVD risk in smokers: REDUCE-IT smoking von Miller, M, Bhatt, D L B, Steg, P G S, Brinton, E A B, Jacobson, T A J, Jiao, L J, Tardif, J C T, Ballantyne, C M B, Budoff, M B, Mason, R P M

Volltext

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease von Cannon, Christopher P, Shah, Sukrut, Dansky, Hayes M, Davidson, Michael, Brinton, Eliot A, Gotto, Antonio M, Stepanavage, Michael, Liu, Sherry Xueyu, Gibbons, Patrice, Ashraf, Tanya B, Zafarino, Jennifer, Mitchel, Yale, Barter, Philip

Volltext

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial von Fox, Kim, Prof, Ford, Ian, Prof, Steg, P Gabriel, Prof, Tendera, Michal, Prof, Ferrari, Roberto, Prof

Volltext

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial von Tardif, Jean-Claude, Dr, McMurray, John JV, MD, Klug, Eric, MD, Small, Robert, PhD, Schumi, Jennifer, PhD, Choi, Jasmine, MSc, Cooper, Jim, Scott, Robert, MD, Lewis, Eldrin F, MD, L'Allier, Philippe L, MD, Pfeffer, Marc A, MD

Volltext

Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib von Cannon, Christopher P., MD, Dansky, Hayes M., MD, Davidson, Michael, MD, Gotto, Antonio M., MD, DPhil, Brinton, Eliot A., MD, Gould, A. Lawrence, PhD, Stepanavage, Michael, MS, Liu, Sherry Xueyu, MS, Shah, Sukrut, RPh, PhD, Rubino, Joseph, MBA, Gibbons, Patrice, MS, Hermanowski-Vosatka, Anne, MD, PhD, Binkowitz, Bruce, PhD, Mitchel, Yale, MD, Barter, Philip, MD, PhD

Volltext

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial von Brinton, Eliot A., MD, Kher, Uma, MS, Shah, Sukrut, PhD, RPh, Cannon, Christopher P., MD, Davidson, Michael, MD, Gotto, Antonio M., MD, DPhil, Ashraf, Tanya B., BA, McCrary Sisk, Christine, BS, Dansky, Hayes, MD, Mitchel, Yale, MD, Barter, Philip, MD, PhD

Volltext

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial von Tardif, Jean-Claude, Ponikowski, Piotr, Kahan, Thomas

Volltext

The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Stud... von Ferrari, R, Ford, I, Fox, K, Steg, P G, Tendera, M

Volltext

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab von Ridker, Paul M, Tardif, Jean-Claude, Amarenco, Pierre, Duggan, William, Glynn, Robert J, Jukema, J. Wouter, Kastelein, John J.P, Kim, Albert M, Koenig, Wolfgang, Nissen, Steven, Revkin, James, Rose, Lynda M, Santos, Raul D, Schwartz, Pamela F, Shear, Charles L, Yunis, Carla

Volltext

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome von Pfeffer, Marc A, Claggett, Brian, Diaz, Rafael, Dickstein, Kenneth, Gerstein, Hertzel C, Køber, Lars V, Lawson, Francesca C, Ping, Lin, Wei, Xiaodan, Lewis, Eldrin F, Maggioni, Aldo P, McMurray, John J.V, Probstfield, Jeffrey L, Riddle, Matthew C, Solomon, Scott D, Tardif, Jean-Claude

Volltext

Effects of Torcetrapib in Patients at High Risk for Coronary Events von Barter, Philip J, Caulfield, Mark, Eriksson, Mats, Grundy, Scott M, Kastelein, John J.P, Komajda, Michel, Lopez-Sendon, Jose, Mosca, Lori, Tardif, Jean-Claude, Waters, David D, Shear, Charles L, Revkin, James H, Buhr, Kevin A, Fisher, Marian R, Tall, Alan R, Brewer, Bryan

Volltext

Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) von Touboul, P.-J., Hennerici, M.G., Meairs, S., Adams, H., Amarenco, P., Bornstein, N., Csiba, L., Desvarieux, M., Ebrahim, S., Hernandez Hernandez, R., Jaff, M., Kownator, S., Naqvi, T., Prati, P., Rundek, T., Sitzer, M., Schminke, U., Tardif, J.-C., Taylor, A., Vicaut, E., Woo, K.S.

Volltext

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia von Bhatt, Deepak L, Steg, P. Gabriel, Miller, Michael, Brinton, Eliot A, Jacobson, Terry A, Ketchum, Steven B, Doyle, Ralph T, Juliano, Rebecca A, Jiao, Lixia, Granowitz, Craig, Tardif, Jean-Claude, Ballantyne, Christie M

Volltext

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stro... von Touboul, P-J, Hennerici, M G, Meairs, S, Adams, H, Amarenco, P, Bornstein, N, Csiba, L, Desvarieux, M, Ebrahim, S, Fatar, M, Hernandez Hernandez, R, Jaff, M, Kownator, S, Prati, P, Rundek, T, Sitzer, M, Schminke, U, Tardif, J-C, Taylor, A, Vicaut, E, Woo, K S, Zannad, F, Zureik, M

Volltext

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction von Tardif, Jean-Claude, Kouz, Simon, Waters, David D, Bertrand, Olivier F, Diaz, Rafael, Maggioni, Aldo P, Pinto, Fausto J, Ibrahim, Reda, Gamra, Habib, Kiwan, Ghassan S, Berry, Colin, López-Sendón, José, Ostadal, Petr, Koenig, Wolfgang, Angoulvant, Denis, Grégoire, Jean C, Lavoie, Marc-André, Dubé, Marie-Pierre, Rhainds, David, Provencher, Mylène, Blondeau, Lucie, Orfanos, Andreas, L’Allier, Philippe L, Guertin, Marie-Claude, Roubille, François

Volltext

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome von Schwartz, Gregory G, Olsson, Anders G, Abt, Markus, Ballantyne, Christie M, Barter, Philip J, Brumm, Jochen, Chaitman, Bernard R, Holme, Ingar M, Kallend, David, Leiter, Lawrence A, Leitersdorf, Eran, McMurray, John J.V, Mundl, Hardi, Nicholls, Stephen J, Shah, Prediman K, Tardif, Jean-Claude, Wright, R. Scott

Volltext

Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus: The AleCardio Randomized Clinical Trial von Lincoff, A. Michael, Tardif, Jean-Claude, Schwartz, Gregory G, Nicholls, Stephen J, Rydén, Lars, Neal, Bruce, Malmberg, Klas, Wedel, Hans, Buse, John B, Henry, Robert R, Weichert, Arlette, Cannata, Ruth, Svensson, Anders, Volz, Dietmar, Grobbee, Diederick E

Volltext

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) von Bouabdallaoui, Nadia, Tardif, Jean-Claude, Waters, David D, Pinto, Fausto J, Maggioni, Aldo P, Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S, Blondeau, Lucie, Orfanos, Andreas, Ibrahim, Reda, Grégoire, Jean C, Dubé, Marie-Pierre, Samuel, Michelle, Morel, Olivier, Lim, Pascal, Bertrand, Olivier F, Kouz, Simon, Guertin, Marie-Claude, L’Allier, Philippe L, Roubille, Francois

Volltext